Follow
Carlos G. Wambier
Carlos G. Wambier
Associate Professor, Clinician Educator, Warren Alpert Medical School of Brown University
Verified email at brown.edu - Homepage
Title
Cited by
Cited by
Year
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated
CG Wambier, A Goren
Journal of the American Academy of Dermatology 83 (1), 308-309, 2020
2562020
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
CG Wambier, S Vaño-Galván, J McCoy, A Gomez-Zubiaur, S Herrera, ...
Journal of the American Academy of Dermatology 83 (2), 680-682, 2020
2142020
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain-A potential clue to the role of androgens in COVID-19 severity
A Goren, S Vano-Galvan, CG Wambier, J McCoy, A Gomez-Zubiaur, ...
J Cosmet Dermatol 19 (7), 1545-1547, 2020
2132020
Androgen sensitivity gateway to COVID‐19 disease severity
CG Wambier, A Goren, S Vaño‐Galván, PM Ramos, A Ossimetha, G Nau, ...
Drug development research 81 (7), 771-776, 2020
1752020
Basic chemical peeling: superficial and medium-depth peels
KC Lee, CG Wambier, SL Soon, JB Sterling, M Landau, P Rullan, ...
Journal of the American Academy of Dermatology 81 (2), 313-324, 2019
1142019
Rational hand hygiene during the coronavirus 2019 (COVID-19) pandemic
G Cavanagh, CG Wambier
Journal of the American Academy of Dermatology 82 (6), e211, 2020
1122020
Racial variations in COVID‐19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti‐androgens a potential …
J McCoy, CG Wambier, S Vano‐Galvan, J Shapiro, R Sinclair, PM Ramos, ...
Journal of cosmetic dermatology 19 (7), 1542, 2020
1072020
What does androgenetic alopecia have to do with COVID‐19? An insight into a potential new therapy
A Goren, J McCoy, CG Wambier, S Vano‐Galvan, J Shapiro, R Dhurat, ...
Dermatologic therapy 33 (4), 2020
872020
Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and Time-to-Remission in males with COVID-19: a randomized, double-blind, placebo …
FA Cadegiani, J McCoy, CG Wambier, A Goren
Cureus 13 (2), 2021
812021
Proxalutamide significantly accelerates viral clearance and reduces time to clinical remission in patients with mild to moderate COVID-19: results from a randomized, double …
FA Cadegiani, J McCoy, CG Wambier, S Vaño-Galván, J Shapiro, A Tosti, ...
Cureus 13 (2), 2021
762021
Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
A Goren, CG Wambier, S Herrera, J McCoy, S Vaño‐Galván, F Gioia, ...
Journal of the European Academy of Dermatology and Venereology 35 (1), e13-e15, 2021
702021
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia
FA Cadegiani, S Herrera
632021
Proxalutamide reduces the rate of hospitalization for COVID-19 male outpatients: a randomized double-blinded placebo-controlled trial
J McCoy, A Goren, FA Cadegiani, S Vaño-Galván, M Kovacevic, M Situm, ...
Frontiers in medicine 8, 2021
612021
Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS)
FA Cadegiani, A Goren, CG Wambier
Medical hypotheses 143, 110112, 2020
612020
Advanced chemical peels: phenol-croton oil peel
CG Wambier, KC Lee, SL Soon, JB Sterling, PP Rullan, M Landau, ...
Journal of the American Academy of Dermatology 81 (2), 327-336, 2019
572019
Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
CG Wambier, S Vaño-Galván, J McCoy, S Pai, R Dhurat, A Goren
Journal of the American Academy of Dermatology 83 (6), e453-e454, 2020
542020
Spironolactone: an anti-androgenic and anti-hypertensive drug that may provide protection against the novel coronavirus (SARS-CoV-2) induced acute respiratory distress syndrome …
FA Cadegiani, CG Wambier, A Goren
Frontiers in Medicine 7, 453, 2020
532020
Time of onset and duration of post-COVID-19 acute telogen effluvium
TF Abrantes, KA Artounian, R Falsey, JCL Simão, S Vañó-Galván, ...
Journal of the American Academy of Dermatology 85 (4), 975-976, 2021
512021
Early COVID-19 therapy with azithromycin plus nitazoxanide, ivermectin or hydroxychloroquine in outpatient settings significantly improved COVID-19 outcomes compared to known …
FA Cadegiani, A Goren, CG Wambier, J McCoy
New microbes and new infections 43, 100915, 2021
502021
Combination tofacitinib and oral minoxidil treatment for severe alopecia areata
CG Wambier, BG Craiglow, BA King
Journal of the American Academy of Dermatology 85 (3), 743-745, 2021
502021
The system can't perform the operation now. Try again later.
Articles 1–20